case_images: PMC9806340_01
case_images: Visual snapshot of significant healthcare events of Patients A and B.
case_images: fimmu-13-1094017-g001.jpg
case_images: PMC9806340_01_fimmu-13-1094017-g001.jpg
case_images: f1
case_images: Details of the patient's clinical course are outlined in  Figure 1 .
case_images: Immunohistochemical analysis of PD-L1 expression on OC cells from Patients A and B (A) Smaller (20x) (upper panels) and larger (40x) (lower panels) magnification of primary OC showing hematoxylin-eosin staining (left panels) and PD-L1+ tumoral cells (right panels) of Patient A (B) Smaller (20x) (upper panels) and larger (40x) (lower panels) magnification of primary OC showing hematoxylin-eosin staining (left panels) and PD-L1+ tumoral cells (right panels) of Patient B Scale bars in A and B are 100 mum.
case_images: fimmu-13-1094017-g002.jpg
case_images: PMC9806340_01_fimmu-13-1094017-g002.jpg
case_images: f2
case_images: Afterward, slides were incubated with VENTANA PD-L1 (SP263) CE IVD US EXPORT antibody. ( Figure 2 ).